Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has provided an announcement.
Shanghai Haohai Biological Technology Co., Ltd. has called its 2025 annual general meeting for 29 May 2026 in Shanghai, where shareholders will review the 2025 board work report, financial report and profit distribution plan, and decide on directors’ remuneration and the 2026 appointment of financial and internal control auditors. The agenda also includes authorizing the board to implement 2026 interim dividends, approving updated remuneration management policies for directors and senior management, electing Ms. Tian Min as an executive director and granting a general mandate to repurchase up to 10% of issued H shares, giving the board broad discretion over buyback terms, capital reduction and related regulatory procedures.
These resolutions, if passed, will shape the company’s capital allocation, governance and leadership structure for the coming year, while the proposed H share repurchase mandate could enhance capital management flexibility and potentially support the share price. The emphasis on profit distribution, interim dividends and formalized remuneration policies underscores a focus on shareholder returns and corporate oversight, with the election of a new executive director signaling a possible strengthening of management resources and strategic execution capacity.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a PRC-incorporated joint stock company listed in Hong Kong, operating in the biomedical sector. The company focuses on the research, development and commercialization of biological products, with its H shares traded under stock code 6826, targeting both domestic and international capital markets.
Average Trading Volume: 163,676
Technical Sentiment Signal: Sell
Current Market Cap: HK$9.56B
Learn more about 6826 stock on TipRanks’ Stock Analysis page.